Influence of COVID-19 pandemic on prevalence and genotype distribution of HPV in cervical cancer screening population

Pešut E, Đukić A, Lulić L, Skelin J, Šimić I, Milutin Gašperov N, Tomaić V, Sabol I, Grce M. Human papillomaviruses-Associated cancers: an update of current knowledge. Viruses 2021, 13.

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71:209–49.

Article  Google Scholar 

Bruni LAG, Serrano B, Mena M, Collado JJ, Gómez D, Muñoz J, Bosch FX, de Sanjosé S. Human papillomavirus and related diseases in China. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). 2021.

Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJF, Peto J, Meijer CJLM, Muoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12–9.

Article  CAS  PubMed  Google Scholar 

Castellsagué X. Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol. 2008;110:S4–7.

Article  PubMed  Google Scholar 

Serrano B, Brotons M, Bosch FX, Bruni L. Epidemiology and burden of HPV-related disease. Best Pract Res Clin Obstet Gynecol. 2018;47:14–26.

Article  Google Scholar 

Bonde J, Bottari F, Iacobone AD, Cocuzza CE, Sandri M-T, Bogliatto F, Khan KS, Ejegod DM, Gary DS, Andrews JC. Human papillomavirus same genotype persistence and risk: a systematic review. J Lower Genit Tract Dis. 2021;25:27–37.

Article  Google Scholar 

Li M, Liu T, Luo G, Sun X, Hu G, Lu Y, Xu H, Zou R, Luo H. Incidence, persistence and clearance of cervical human papillomavirus among women in Guangdong, China 2007–2018: a retrospective cohort study. J Infect Public Health. 2021;14:42–9.

Article  CAS  PubMed  Google Scholar 

Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, Arbyn M, Basu P, Bray F, Vaccarella S. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Global Health. 2023;11:e197–206.

Article  CAS  PubMed  Google Scholar 

WHO. WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19–11 March 2020. 2020.

Pujolar G, Oliver-Anglès A, Vargas I, Vázquez M-L. Changes in Access to Health Services during the COVID-19 pandemic: a scoping review. Int J Environ Res Public Health 2022, 19.

Tuczyńska M, Matthews-Kozanecka M, Baum E. Accessibility to Non-COVID Health Services in the World during the COVID-19 pandemic: review. Front Public Health 2021, 9.

Simms KT, Steinberg J, Caruana M, Smith MA, Lew J-B, Soerjomataram I, Castle PE, Bray F, Canfell K. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study. Lancet Oncol. 2019;20:394–407.

Article  PubMed  Google Scholar 

Hildesheim A, Gonzalez P, Kreimer AR, Wacholder S, Schussler J, Rodriguez AC, Porras C, Schiffman M, Sidawy M, Schiller JT, et al. Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment. Am J Obstet Gynecol. 2016;215:e212211–5.

Article  Google Scholar 

Ortiz AP, Gierbolini-Bermúdez A, Ramos-Cartagena JM, Colón-López V, Sonawane K, Deshmukh AA, Ortiz-Ortiz KJ. Cervical Cancer Screening among Medicaid patients during Natural disasters and the COVID-19 pandemic in Puerto Rico, 2016 to 2020. JAMA Netw Open 2021, 4.

Yu H, Yi J, Dou Y-l, Chen Y, Kong L-j, Wu J. Prevalence and Genotype Distribution of Human Papillomavirus among Healthy Females in Beijing, China, 2016–2019. Infect Drug Resist. 2021;14:4173–82.

Article  PubMed  PubMed Central  Google Scholar 

Zhu X, Wang Y, Lv Z, Su J. Prevalence and genotype distribution of high-risk HPV infection among women in Beijing, China. J Med Virol. 2021;93:5103–9.

Article  CAS  PubMed  Google Scholar 

Long W, Yang Z, Li X, Chen M, Liu J, Zhang Y, Sun X. HPV-16, HPV-58, and HPV-33 are the most carcinogenic HPV genotypes in Southwestern China and their viral loads are associated with severity of premalignant lesions in the cervix. Virol J 2018, 15.

Xiang F, Guan Q, Liu X, Xiao H, Xia Q, Liu X, Sun H, Song X, Zhong Y, Yuan CH, Xiang Y. Distribution characteristics of different human papillomavirus genotypes in women in Wuhan, China. J Clin Lab Anal 2018, 32.

Yang X, Li Y, Tang Y, Li Z, Wang S, Luo X, He T, Yin A, Luo M. Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021. Emerg Microbes Infections 2023, 12.

Zhao S, Zhao X, Hu S, Lu J, Duan X, Zhang X, Chen F, Zhao F. Distribution of high-risk human papillomavirus genotype prevalence and attribution to cervical precancerous lesions in rural North China. Chin J Cancer Res. 2019;31:663–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McCredie MRE, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, Skegg DCG. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 2008;9:425–34.

Article  PubMed  Google Scholar 

Zheng L-l, Chen S-f, Yang F, Wang W-h, Xu C, Zheng L-y. High-risk HPV prevalence and genotype distribution among women in Liaocheng, Shandong Province, China from 2016 to 2022. Front Public Health 2023, 11.

Zhang W, Guo N, Li B, Shang E, Wang J, Zhang M, Yang X. Prevalence and genotype distribution of human papillomavirus infections in Beijing, China between 2016 and 2020. Virol J 2023, 20.

Serra IGSS, Araujo ED, Barros GS, Santos FLSG, Gurgel RQ, Batista MVA. Prevalence of human papillomavirus types associated with cervical lesions in Sergipe state, Northeastern Brazil: high frequency of a possibly carcinogenic type. Epidemiol Infect. 2018;146:1184–93.

Article  CAS  PubMed  Google Scholar 

Ouedraogo RA, Zohoncon TM, Guigma SP, Angèle Traore IM, Ouattara AK, Ouedraogo M, Djigma FW, Obiri-Yeboah D, Ouedraogo C, Simpore J. Oncogenic human papillomavirus infection and genotypes characterization among sexually active women in Tenkodogo at Burkina Faso, West Africa. Papillomavirus Res. 2018;6:22–6.

Article  PubMed  PubMed Central  Google Scholar 

Martora F, Della Pepa ME, Grimaldi E, Franci G, Folliero V, Petrillo A, Schettino MT, De Franciscis P, Galdiero M, Galdiero M. Seven years prevalence and distribution of high and low risk HPV genotypes in women living in the metropolitan area of Naples. Cancer Epidemiol 2019, 63.

Juárez-González K, Paredes-Cervantes V, Gordillo-Rodríguez S, González-Guzmán S, Moncayo-Valencia X, Méndez-Martínez R, García-Carrancá A, Martínez-Ezquerro JD, Rivas-Ruiz R, Sánchez-Suárez P, et al. High prevalence of human papillomavirus type 66 in low-grade cervical lesions of Mexican women. Arch Virol. 2020;165:2633–40.

Article  PubMed  Google Scholar 

Louvanto K, Rintala Marjut A, Syrjänen Kari J, Grénman Seija E, Syrjänen Stina M. Genotype-specific persistence of Genital Human Papillomavirus (HPV) infections in women followed for 6 years in the Finnish Family HPV Study. J Infect Dis. 2010;202:436–44.

Article  PubMed  Google Scholar 

Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJF, Meijer CJLM. Epidemiologic classification of human papillomavirus types Associated with Cervical Cancer. N Engl J Med. 2003;348:518–27.

Article  PubMed  Google Scholar 

Trottier H, Mahmud S, Costa MC, Sobrinho JoP, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev. 2006;15:1274–80.

Article  CAS  PubMed  Google Scholar 

Chaturvedi AK, Katki HA, Hildesheim A, Rodríguez AC, Quint W, Schiffman M, Van Doorn L-J, Porras C, Wacholder S, Gonzalez P, et al. Human papillomavirus infection with multiple types: pattern of Coinfection and Risk of Cervical Disease. J Infect Dis. 2011;203:910–20.

Article  PubMed  PubMed Central  Google Scholar 

Wentzensen N, Nason M, Schiffman M, Dodd L, Hunt WC, Wheeler CM. No evidence for synergy between human papillomavirus genotypes for the risk of high-Grade squamous intraepithelial lesions in a large Population-based study. J Infect Dis. 2014;209:855–64.

Article  PubMed  Google Scholar 

Li T, Chen S, Li X, Wu Z, Zhao Y, Cui J, Liu B, Chen F, Zhang X, Qiao Y, Chen W. The features of high-risk human papillomavirus infection in different female genital sites and impacts on HPV-based cervical cancer screening. Virol J 2023, 20.

Wendland EM, Villa LL, Unger ER, Domingues CM, Benzaken AS, Maranhão AGK, Kops NL, Bessel M, Caierão J, Hohenberger GF et al. Prevalence of HPV infection among sexually active adolescents and young adults in Brazil: the POP-Brazil Study. Sci Rep 2020, 10.

Wu J, Ding C, Liu X, Zhou Y, Tian G, Lan L, Chen C, Yan D, Huang C, Fu X, et al. Worldwide burden of genital human papillomavirus infection in female sex workers: a systematic review and meta-analysis. Int J Epidemiol. 2021;50:527–37.

Article  PubMed  Google Scholar 

Yang J, Wang W, Wang Z, Wang Z, Wang Y, Wang J, Zhao W, Li D, Liu H, Hao M. Prevalence, genotype distribution and risk factors of cervical HPV infection in Yangqu, China: a population-based survey of 10086 women. Hum Vaccines Immunotherapeutics. 2019;16:1645–52.

Article  Google Scholar 

Gountas I, Favre-Bulle A, Saxena K, Wilcock J, Collings H, Salomonsson S, Skroumpelos A, Sabale U. Impact of the COVID-19 pandemic on HPV vaccinations in Switzerland and Greece: Road to Recovery. Vaccines 2023, 11.

Cruz-Valdez A, Palacio-Mejía LS, Quezada-Sánchez AD, Hernández-Ávila JE, Galicia-Carmona T, Cetina-Pérez LdC, Arango-Bravo EA, Isla-Ortiz D, Aranda-Flores CE, Uscanga-Sánchez S-R et al. Cervical cancer prevention program in Mexico disrupted due to COVID-19 pandemic: challenges and opportunities. Front Oncol 2023, 13.

留言 (0)

沒有登入
gif